Dronedarone in Pacemakers Patients With Paroxysmal Atrial Fibrillation

Summary

The purpose of this study is to accurately investigate the efficacy of dronedarone in maintaining sinus rhythm and decreasing AFB in patients with paroxysmal atrial fibrillation as compared with placebo. This has never previously been performed using pacemaker Holter monitoring which provides detailed information of atrial arrhythmia patterns the entire study period. Additionally detailed patient symptom self assessment and questionnaires will be collected. The study design will be double blinded crossover with each phase lasting 3 months.

Timeline

Start

2010-03

Primary completion

2010-03

Completion

2010-03

Drugs

Indications